Louis Leblanc

407 total citations
11 papers, 197 citations indexed

About

Louis Leblanc is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Louis Leblanc has authored 11 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Oncology and 3 papers in Hepatology. Recurrent topics in Louis Leblanc's work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Louis Leblanc is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Louis Leblanc collaborates with scholars based in France, United States and Senegal. Louis Leblanc's co-authors include R Masseyeff, Kai Krohn, AlfredM. Prince, Alfred M. Prince, W. Szmuness, C Quénum, Pascal Eschwège, J Uriel, F Loisillier and P Grabar and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Journal of Epidemiology.

In The Last Decade

Louis Leblanc

10 papers receiving 165 citations

Peers

Louis Leblanc
Comparison fields: 5 of 43
  • Epidemiology 110
  • Hepatology 82
  • Surgery 41
  • Molecular Biology 31
  • Pharmacology 21
Replace Lin Tm with:
Lin Tm Taiwan
Stefan Lueth Germany
Hiroshi Kamitsukasa Japan
Kai‐Chi Chang Taiwan
Costanza Sbreglia Italy
Thierry Paupard France
Mohamed A. Metwally Egypt
JAW‐CHING WU Taiwan
Hesham M. Elgouhari United States
Kate D. Lynch Australia
Lin Tm Taiwan View profile →
Citations per field, relative to Louis Leblanc
Louis Leblanc · 1×
Citations per year, relative to Louis Leblanc
Louis Leblanc · 1×

Countries citing papers authored by Louis Leblanc

Since Specialization
Citations

This map shows the geographic impact of Louis Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Leblanc more than expected).

Fields of papers citing papers by Louis Leblanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Leblanc. The network helps show where Louis Leblanc may publish in the future.

Co-authorship network of co-authors of Louis Leblanc

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Leblanc. A scholar is included among the top collaborators of Louis Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Leblanc. Louis Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 0
2 6
3 19
4 56
5 7
6
[Production of alpha-1-fetoprotein during the course of primary carcinoma of the liver (apropos of 83 cases)].
1
7 60
8
[Value of the study of serum alpha-1-feto-protein in diagnosis of primary cancer of the liver].
6
9
[Diagnosis of primary carcinoma of the liver by demonstration in the serum of an embryonal alpha globulin].
8
10
[Diagnosis of primary cancer of the liver by immunological methods].
28
11
[Embryonal antigens and cancer of the liver in man. Association of serum alpha 1-fetoprotein with primary hepatoma].
6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026